Go back to Resource Center
Clinical trials referral resource. Current clinical trials of cilengitide, an alpha(v) antagonist in clinical development as an anticancer agent.
2004 Dec
Journal Article
Authors:
Colevas, D.;
Scharf, O.;
Schoenfeldt, M.
Secondary:
Oncology (Williston Park)
Volume:
18
Pagination:
1778, 1781-2, 1784
Issue:
14
PMID:
15700626
Keywords:
Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Integrin alphaV; Neoplasms; Snake Venoms
